The New England journal of medicine 2021 Mar 25
The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors.
Related Questions
New answer by Medical Oncologist at NYU Long Island School of Medicine (November 22, 2023)
Circulating tumor DNA has a consistently higher TMB than tissue. As noted by Dr. @Jin, MSKCC has demonstrated (Rousseau et al., PMID 33761214) no benefit for patients that are...